Clinical Trial Report

By No Comments
PLAQUE PSORIASISA Long Term Study to Evaluate the Safety and Tolerability of CP-690,550 for Patients With Moderate to Severe Chronic Plaque Psoriasis Sponsored by Pfizer, the main objective of this…
Read More

Pipeline Previews

By No Comments
FDA Approves Cosentyx for PsoriasisNovartis has announced that the FDA has approved Cosentyx for the treatment of moderate-to-severe plaque psoriasis in adult patients who require systemic therapy or phototherapy (light…
Read More

Infantile Hemangiomas

By No Comments
Shanna Spring MD University of California, San Francisco, CA and The Hospital for Sick Children, Toronto, ONIlona J. Frieden MD Birthmarks and Vascular Anomalies Center and Division of Pediatric Dermatology,…
Read More